Martin Nicklasson
Joining Sørensen in Orexo news is current Chairman of the Board Martin Nicklasson who has been appointed Executive Chairman.
Prior to joining Orexo in 2012, Nicklasson spent four years as CEO of Biovitrum and 16 years with Astra and AstraZeneca.
“My principal focus will be to maximize value of the assets for the company and its shareholders,” Nicklasson said. “I’m looking forward to working with Nikolaj Sørensen and the leadership team towards this common goal.”